Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Epinephrine and Nicotine

supplement:

Epinephrine

Research Papers that Mention the Interaction

Nicotine significantly increased the systemic levels of adrenaline , noradrenaline and cAMP while increasing xenograft size and protein levels of cAMP, cyclic AMP response element-binding protein and p-extracellular signal-regulated kinase 1/2 in the tumor tissue.
Carcinogenesis  •  2009  |  View Paper
Cotinine formation from nicotine was inhibited by tryptamine (Ki = 0.7 μM, competitive), serotonin (Ki = 272 μM, noncompetitive), dopamine, noradrenaline, and adrenaline (Ki = 11 μM, 54 μM, and 81 μM, uncompetitive).
Drug Metabolism and Disposition  •  2007  |  View Paper
…,nicotine, … epinephrine and norepinephrine release, and enhances vasoconstriction by impairing endothelium-dependent and endotheliumindependent vasodilation; it may therefore hinder tissue perfusion.9,10 In this randomized, … regular current snus users (one or more sachets daily in the last 30 days).11 Their ages ranged from 18 to 45 years.
Vascular medicine  •  2020  |  View Paper
The interaction of nicotine with the HT-29 cells stimulated the epinephrine secretion causing an increase in epinephrine release concentration, and enabling the conclusion that epinephrine and nicotine play an important role in the colorectal tumour growth.
Bioelectrochemistry  •  2013  |  View Paper
In the present study, we showed that nicotine stimulated HT-29 cell proliferation and adrenaline production in a dose-dependent manner.
Toxicology and applied pharmacology  •  2007  |  View Paper
The pattern of haemodynamic changes in the forearm indicates that epinephrine may be the mediator of the circulatory effects of nicotine.
European Journal of Clinical Pharmacology  •  2004  |  View Paper
Nicotine interacted with the response of adrenergic agonists both in arteries and veins; in arteries it potentiates the contractile response of epinephrine ; in veins, it inhibited the dilatory responses of norepinephrine and potentiated the contractile effect of high concentration of epinephrine (10(-6) M).
Pharmacology & toxicology  •  1994  |  View Paper
Nicotine caused a significant dose-dependent increase in the plasma levels of nicotine, cotinine, noradrenaline, adrenaline , glycerol and free fatty acids (FFA).
Nicotine produced significant elevations of adrenaline , glycerol and FFA concentrations at both doses (maximal increments of 247, 184 and 153%, respectively) and the peak effect occurred at 30 min.
Serum noradrenaline, adrenaline , glycerol and FFA levels had increased significantly by 15 min of nicotine infusion.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity  •  1993  |  View Paper
Nicotine has been shown to lead to increases in plasma epinephrine and norepinephrine following smoking.
The Journal of family practice  •  1989  |  View Paper
Nicotine reversed ADP-induced aggregation, the effect of nicotine was potentiated by isoprenaline and theophylline and inhibited by adrenaline.
Atherosclerosis  •  1974  |  View Paper
Show More